Statistics

Total Visits

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)64

Select a period of time:

Number of views in the range

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)29

Views

Views
January 20253
February 202510
March 202510
April 20253
May 20251
June 20251
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States11
United Kingdom2
Brazil1
Spain1
 

Top cities views

Views
Council Bluffs1
Duque de Caxias1
Huntington Beach1